How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach.

Mednet Member

Medical Oncology · H Lee Moffitt Cancer Center, University of South Florida

Doing a 5FU/capecitabine rechallenge after vasospasm can be risky and fatalities have been reported. Capecitabine and infusion 5FU are riskier than bolus 5FU due to prolonged exposure of the endothelium to metabolites. In the US, we lack access to safer alternatives like S1. There are some reports o...